Debarshi Lahiri

  • Citations Per Year
Learn More
BACKGROUND The concurrent chemoradiotherapy for cervical cancer treatment is well accepted since 1999. This randomized, phase III trial aimed to observe if any improved outcome could be obtained capitalizing on the synergistic activity of gemcitabine, cisplatin, XRT. MATERIALS AND METHODS Stage IIB-IIIB, 18-70 years of age, KPS score ≥70, were randomized(More)
CONTEXT Sequential induction chemotherapy with cisplatin and 5-fluorouracil (PF) along with interferon-alpha2b and concurrent chemoradiation offers superior loco-regional control for locally advanced carcinoma of oral tongue. AIMS The study was designed to evaluate the beneficial role of induction PF chemotherapy and interferon-alpha2b followed by(More)